XO
XOSWW
Xos, Inc.
$0.003800
0.00%
$24.2K
No data for this timeframe.
Vol
Market Cap$24.2K
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$8.00
SEC Reports4
Exchange Nasdaq·Sector Motor Vehicle Parts & Accessories·Inc. DE·CIK 0001819493·Prev Close $0.003800
Recent Activity
May 14, 2026
SEC
Xos reported Q1 2026 revenue of $11.2M, up 91% YoY from $5.9M, with record gross margin of 38.6% (vs 20.6% a year ago) a
8-K — Impact 7/10
May 13, 2026
SEC
Xos entered into a Third Amended and Restated Convertible Promissory Note with Aljomaih Automotive Co., reducing the con
8-K — Impact 3/10
May 4, 2026
SEC
Xos, Inc. filed additional definitive proxy materials (DEFA14A) on May 4, 2026. The filing contains graphic images but n
DEFA14A — Impact 2/10
Latest Reports
BULLISH
8-K
7/10
Xos reported Q1 2026 revenue of $11.2M, up 91% YoY from $5.9M, with record gross margin of 38.6% (vs 20.6% a year ago) a
May 14, 2026
NEUTRAL
8-K
3/10
Xos entered into a Third Amended and Restated Convertible Promissory Note with Aljomaih Automotive Co., reducing the con
May 13, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| UBS Group AG | $8.00 | — |
1 institutional holders with $8.00 total value (698 shares) as of 2025-Q3. Top holders: UBS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | UBS Group AG | 698 | $8.00 | 100.0% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 3.8/10.
BULLISH
8-K
7/10
Xos reported Q1 2026 revenue of $11.2M, up 91% YoY from $5.9M, with record gross margin of 38.6% (vs
May 14, 2026
NEUTRAL
8-K
3/10
Xos entered into a Third Amended and Restated Convertible Promissory Note with Aljomaih Automotive C
May 13, 2026
NEUTRAL
DEFA14A
2/10
Xos, Inc. filed additional definitive proxy materials (DEFA14A) on May 4, 2026. The filing contains
May 4, 2026
NEUTRAL
10-K/A
3/10
Xos, Inc. filed an amended 10-K to include omitted critical audit matters in its auditor's report an
Apr 21, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
No analyst rating data available yet. Consensus ratings and individual firm actions are collected periodically from financial data providers.
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.